Compare SAH & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SAH | ADMA |
|---|---|---|
| Founded | 1997 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.4B |
| IPO Year | 1997 | 2012 |
| Metric | SAH | ADMA |
|---|---|---|
| Price | $76.50 | $10.29 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 4 |
| Target Price | ★ $78.25 | $25.67 |
| AVG Volume (30 Days) | 170.3K | ★ 4.6M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.07% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.79 | 0.60 |
| Revenue | ★ $9,951,630,000.00 | $42,219,783.00 |
| Revenue This Year | $4.61 | $27.46 |
| Revenue Next Year | $4.16 | $22.11 |
| P/E Ratio | $42.61 | ★ $17.58 |
| Revenue Growth | 0.86 | ★ 43.85 |
| 52 Week Low | $54.11 | $7.21 |
| 52 Week High | $89.38 | $23.98 |
| Indicator | SAH | ADMA |
|---|---|---|
| Relative Strength Index (RSI) | 67.05 | 40.16 |
| Support Level | $71.28 | $7.21 |
| Resistance Level | $77.85 | $11.42 |
| Average True Range (ATR) | 3.40 | 0.45 |
| MACD | 0.55 | 0.12 |
| Stochastic Oscillator | 66.95 | 12.36 |
Sonic Automotive is one of the largest auto dealership groups in the United States. The company has 111 franchised stores in 18 states, primarily in metropolitan areas in California, Texas, and the Southeast, plus 18 EchoPark used-vehicle stores in 10 states, 16 collision centers, and 14 powersports locations. The franchise stores derive revenue from new and used vehicles plus parts and collision repair, finance, insurance, and wholesale auctions. Luxury and import dealerships make up about 86% of franchise new-vehicle revenue, while Honda, BMW, Mercedes, and Toyota constitute about 56% of new-vehicle revenue. BMW is the largest brand at about 23%. 2025's revenue was $15.2 billion, with Texas and California comprising 51% of the total. EchoPark's portion was $2.1 billion.
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.